Skip to main content
. 2022 Apr 26;14(9):1810. doi: 10.3390/nu14091810

Table 1.

Effects on glycemic control and metabolic parameters.

Retrospective Baseline Follow-Up Change p-Value
−3 months +3 months
n = 42 *
HbA1c (%)
Control group
8.2 ± 1.3 7.9 ± 1.0 - −0.3 ± 1.1 0.27
HbA1c (%)
Intervention group
- 7.9 ± 1.0 6.9 ± 0.9 −0.9 ± 1.1 <0.001
n = 37 *
Intervention group
Weight (kg) - 105.2 ± 18.5 100.9 ± 17.6 −4.3 ± 4.5 <0.001
BMI (kg/m2) - 35.1 ± 7.3 33.6 ± 7.1 −1.4 ± 1.5 <0.001
Waist circumference (cm) - 121.1 ± 16.5 115.4 ± 17.4 −5.7 ± 15.0 0.03
Fasting glucose (mmol/L) - 7.4 ± 1.4 6.8 ± 1.5 −0.6 ± 1.3 0.01

* Metabolic parameters and HbA1c were recorded separately in the intervention group, resulting in a different sample size. Metabolic parameters were only recorded in the intervention group.